Urgent.News

What's breaking now, across thousands of outlets.

World

Kunal Kamra takes a dig at Deepinder Goyal over Temple wearable, questions scientific claims

Deepinder Goyal has defended his experimental Temple wearable after doctors raised concerns about its scientific claims, citing $30 million in investment and promising further validation. Comedian Kunal Kamra responded with a pointed post on X, questioning the entrepreneur’s arguments.

Kunal Kamra takes a dig at Deepinder Goyal over Temple wearable, questions scientific claims

Comedian Kunal Kamra has criticized entrepreneur Deepinder Goyal over the Temple wearable, questioning the scientific claims made about the device. The controversy arose after Goyal addressed concerns raised by doctors about Temple's ability to measure real-time blood flow in the brain. Kamra mocked Goyal's defense, pointing out that it primarily relied on his personal investment and confidence in the technology rather than addressing the scientific concerns.

Goyal defended Temple's business model and scientific validation efforts, stating that the company had invested $30 million in the device, with $20 million of that amount coming from Goyal himself. He argued that selling a few thousand units would recover only a small portion of the investment. He also highlighted the company's 14-day, no-questions-asked return policy, emphasizing that if Temple were a scam, customers would know within days of using it, causing the company to fail before recovering any R&D costs.

Goyal explained that he left his CEO role at Eternal to pursue Temple as a purpose-driven project and emphasized that his financial security meant he was not driven by quick monetary gains. He indicated that pre-prints of the device's validation were expected before peer-reviewed publications and that the company held itself to a higher standard compared to other wearable technology companies.

Goyal claimed that Temple had reached a stage where it was valuable enough for consumers to pay for and use, while further validation continued. He also stated that the company's claims could be verified by individuals and institutions and that independent studies would emerge once the device became available for use. However, some of Temple's features remained undisclosed at the time of the controversy.

Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at livemint.com →

More in World

More from Friday 6 November →